JAGUAR HEALTH, INC. Common Stock, Capital Shares Reserved for Future Issuance
JAGUAR HEALTH, INC. (JAGX) had Common Stock, Capital Shares Reserved for Future Issuance of 168.94 thousand shares as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes › Stockholders' Equity Note › Class of Stock Disclosures
us-gaap:CommonStockCapitalSharesReservedForFutureIssuance · last filed 2026-08-19
- 2026-06-30: Common Stock, Capital Shares Reserved for Future Issuance 168.94K shares.
- 2026-03-31: Common Stock, Capital Shares Reserved for Future Issuance 299.50K shares.
- 2025-12-31: Common Stock, Capital Shares Reserved for Future Issuance 116.79K shares; Common Stock, Capital Shares Reserved for Future Issuance as first filed 4.09M shares.
- 2025-09-30: Common Stock, Capital Shares Reserved for Future Issuance 2.95M shares.
| Period end | Common Stock, Capital Shares Reserved for Future Issuance | Common Stock, Capital Shares Reserved for Future Issuance as first filed |
|---|---|---|
| 2026-06-30 | 168.94K shares 10-Q · filed 2026-08-19 | |
| 2026-03-31 | 299.50K shares 10-Q · filed 2026-05-20 | |
| 2025-12-31 | 116.79K shares 10-Q · filed 2026-08-19 | 4.09M shares 10-K · filed 2026-04-07 |
| 2025-09-30 | 2.95M shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 2.16M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 732.81K shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 51.43K shares 10-K · filed 2026-04-07 | |
| 2024-09-30 | 1.46M shares 10-Q · filed 2024-11-13 | |
| 2024-06-30 | 997.96K shares 10-Q · filed 2024-08-13 | |
| 2024-03-31 | 11.60M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 8.14K shares 10-K · filed 2025-03-31 | 14.79M shares 10-K · filed 2024-04-01 |
| 2023-09-30 | 14.79M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 11.34M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 203.43K shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 203.43K shares 10-K · filed 2024-04-01 | |
| 2022-09-30 | 7.07M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 7.07M shares 10-Q · filed 2022-08-22 | |
| 2022-03-31 | 6.91M shares 10-Q · filed 2022-05-10 | |
| 2021-12-31 | 55.72K shares 10-K · filed 2023-03-24 | 4.19M shares 10-K · filed 2022-03-11 |
| 2021-09-30 | 4.19M shares 10-Q · filed 2021-11-17 | |
| 2021-06-30 | 12.56M shares 10-Q · filed 2021-08-13 | |
| 2021-03-31 | 4.19M shares 10-Q · filed 2022-05-10 | 12.57M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 4.13M shares 10-K · filed 2022-03-11 | 12.38M shares 10-K · filed 2021-03-31 |
| 2020-09-30 | 13.95M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 24.07M shares 10-Q · filed 2020-08-13 | |
| 2020-03-31 | 28.63M shares 10-Q · filed 2020-05-15 | |
| 2019-12-31 | 27.20M shares 10-K · filed 2021-03-31 | |
| 2019-09-30 | 25.26M shares 10-Q · filed 2019-11-14 | |
| 2019-06-30 | 1.77M shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | 43.19M shares 10-Q · filed 2019-05-21 | |
| 2018-12-31 | 145.87K shares 10-K · filed 2020-04-03 | 6.90M shares 10-K · filed 2019-04-10 |
| 2018-09-30 | 6.51M shares 10-Q · filed 2018-11-19 | |
| 2018-06-30 | 4.77M shares 10-Q · filed 2018-08-13 | |
| 2018-03-31 | 69.11M shares 10-Q · filed 2018-05-15 | |
| 2017-12-31 | 5.37M shares 10-K · filed 2019-04-10 | 29.21M shares 10-K · filed 2018-04-09 |
| 2017-09-30 | 5.37M shares 10-Q · filed 2018-11-19 | 31.60M shares 10-Q · filed 2017-11-20 |
| 2017-06-30 | 621.45K shares 10-Q · filed 2018-08-13 | 11.45M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 9.32M shares 10-Q · filed 2018-05-15 | |
| 2016-12-31 | 8.67M shares 10-K · filed 2018-04-09 | |
| 2016-09-30 | 3.37M shares 10-Q · filed 2017-11-20 | |
| 2016-06-30 | 3.41M shares 10-Q · filed 2017-08-09 | |
| 2016-03-31 | 1.96M shares 10-Q/A · filed 2017-06-23 | |
| 2015-12-31 | 1.86M shares 10-K · filed 2017-02-15 | 1.83M shares 10-K · filed 2016-03-29 |
| 2014-12-31 | 1.34M shares 10-K · filed 2016-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |